$31.45 - VRDN | Viridian Therapeutics, Inc. Common Stock

Viridian Therapeutics, Inc. Common Stock (VRDN)

Viridian Therapeutics, Inc. Common Stock

XNAS:VRDN

31.45

-1.60%

Ask

$32.36 - 15.00

Bid

$31.00 - 75.00

Low

$31.06

High

$31.93

Open

$31.56

Prev Close

$31.96

52W High

32.54

52W Low

9.9

Volume

1112598

Avg Vol (3m)

1948184.6

Float

85963654.98

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 06/18/2014

Primary Exchange: XNAS

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Phone: 617.272.4600

Address: 221 Crescent Street

Address 2: Suite 103a

City: Waltham

State: MA

Postal Code: 02453

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

143

P/E (TTM)

-9.040000

P/B (TTM)

8.367300

EPS

-0.34

Round Lot

100

Composit FIGI

BBG002H242Z5

Share Class FIGI

BBG002H24301

Share Class Shares Outstanding

81.67M

Weighted Shares Outstanding

95.37M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion